As global temperatures rise, more regions are experiencing heat levels that exceed the human body’s ability to cool itself. Scientists reveal how record-breaking heat waves are pushing past survival thresholds, making urgent climate action and adaptation critical.
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial – Pharmaceutical Technology
Tezspire is a thymic stromal lymphopoietin (TSLP) inhibiting monoclonal antibody, which generated $86m in sales in 2023. Image credit: eamesBot / Shutterstock. AstraZeneca and Amgen